Covid-19 Response and Resources

The NH-INBRE leadership is following the NIH guidance in the quickly changing times of the COVID-19 world. We have been monitoring the COVID-19 updates and news from our partners.  Dartmouth is also undergoing changes with lab closures and remote scholarly work, so we understand the shifting environment that our Partners are going through as well.  Our intention is to provide you all with appropriate guidance as we find out and to provide support in the coming weeks/months.

Q and A


  • I am quarantined, self-isolated, or caring for a sick family member can I request an extension to my NH-INBRE annual reporting?

Annual progress reports for all funded faculty, RSTG supported faculty, and Institutional RSTG Leaders are due April 15th.  As the progress reporting for NH-INBRE Partners is completed online we will not be issuing an extension for the annual reporting.  If you are effected by COVID-19 beyond working remotely and cannot submit the progress report materials by the due date please contact Jennifer Smith. 


  • I am working remotely from home in self-isolation. Can my effort still be charge to the grant?

If your institution’s policy allows for charging salaries and benefits during periods when no work is performed due to the effect of COVID-19, then such charges to NIH grant awards will be allowable. This includes salary and benefits for RSTG students and staff receiving effort from INBRE. Please have this policy available if documentation is requested by NIH.


  • Are travel cancellation costs due to COVID-19 allowable as direct charges to sponsored projects?

Non-refundable costs associated with grant-related travel that has been cancelled due to COVID-19 may be charged to the NIH award if they would have otherwise been allowable. See NIH GPS 7.9.1 for detailed information on the allowability of travel expenses.

Non-refundable registration fees for conferences, symposiums or seminars that have been cancelled due to COVID19 may be charged to the NIH award if they would have otherwise been allowable (e.g. necessary to accomplish program objectives).



Guidance from Federal Sponsors on Grant Related Issues

Dept of Energy Special Announcement for Applicants and Awardees announcing flexibilities due to COVID-19.
DOD CDMRP COVID-19 FAQs for Grant Applicants and Recipients (Version 1, March 16, 2020)
NASA Current operating status of NASA, Travel advisory
NEH NEH Information for Grantees
NSF Frequently Asked Questions (FAQs) for NSF Proposers and Awardees
NSF Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)
NSF Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Panelists
March 17, 2020
NSF Impact on Existing Deadline Dates March 18, 2020
NIH Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19, NOT-OD-20-086, March 12, 2020
NIH General Frequently Asked Questions (FAQs) – Proposal Submission and Award Management Related to COVID-19, March 10, 2020
NIH The NIH web page on natural disasters and other emergencies has information that NIH might implement in the case of a natural disaster.
NIH NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
NIH Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
NIH NIH Guidance on Travel and Meetings
COGR The Council on Government Relations has created a website for agency notices and other resources.

Funding Announcements

Bill & Melinda Gates Foundation COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic
Biomedical Advanced Research and Development Authority (BARDA) Broad agency announcement (BAA) on March 6, 2020 to focus specifically on products to diagnose, prevent or treat coronavirus infections
Centers for Disease Control Centers for Disease Control COVID-19 Broad Agency Announcement
Department of Energy RAPID REQUEST: Coronavirus Disease 2019 (COVID-19) Dear Colleague Letter.
Asking for input on COVID-19 rapid research response involving DOE user facilities and infrastructure.Invitation for COVID-19 scientific questions
NIH NIAID’s Multi-Pronged Response to the COVID-2019 OutbreakAdministrative Supplements
New Tool for SARS-CoV-2/COVID-2019 Response
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
NIH Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
NIH Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)
NSF Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)
NSF NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
Office of Science and Technology Policy, White House Release of COVID-19 Open Research Dataset (CORD-19) of scholarly literature about COVID-19, SARS-CoV-2, and the Coronavirus group.
Call to action to the Nation’s artificial intelligence experts to develop new text and data mining techniques that can help the science community answer high-priority scientific questions related to COVID-19.
Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset